Literature DB >> 10498252

Partial functional correction of xeroderma pigmentosum group A cells by suppressor tRNA.

R G Panchal1, S Wang, J McDermott, C J Link.   

Abstract

Genetic diseases are often caused by nonsense mutations. The resulting defect in protein translation can be restored by expressing suppressor tRNA in the mutant cells. Our goal was to demonstrate both protein restoration and phenotypic correction using these small transgenes. Functional activity of an arginine opal suppressor tRNA in cells expressing a nonsense mutated GFP gene was demonstrated by restored fluorescence. This suppressor tRNA was expressed in xeroderma pigmentosum group A cells, containing a homozygous nonsense mutation at Arg-207 in the XPA complementing gene. The transfected XPA cell population showed a twofold increase in cell survival after UV irradiation as determined by colony-forming assays compared with cell populations without the suppressor tRNA gene. The UV doses required for 37% survival of XP cells and XP cells expressing the suppressor tRNA were 0.6 and 1.2 J/m2. A similar twofold increase in the reactivation of UV-irradiated plasmid DNA was observed in XP cells expressing the suppressor tRNA. However, there was no detectable increase in XPA protein levels. Several potential limitations of this approach exist, including the availability of mutant RNA transcripts, the efficiency of suppression by the suppressor tRNA, and the abundance and availability and continued expression of the suppressor tRNA. The unique feature of this study is the relatively small size (88 bp) of the suppressor tRNA. Small-sized suppressor tRNAs can be synthetically constructed and subcloned into different viral vectors for delivery into the target cells. This approach may be useful for other genetic diseases caused by nonsense mutations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10498252     DOI: 10.1089/10430349950017194

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  14 in total

1.  Import of amber and ochre suppressor tRNAs into mammalian cells: a general approach to site-specific insertion of amino acid analogues into proteins.

Authors:  C Köhrer; L Xie; S Kellerer; U Varshney; U L RajBhandary
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Functional analysis of human tRNA isodecoders.

Authors:  Renaud Geslain; Tao Pan
Journal:  J Mol Biol       Date:  2009-12-21       Impact factor: 5.469

3.  Suppression of nonsense mutations in cell culture and mice by multimerized suppressor tRNA genes.

Authors:  M Buvoli; A Buvoli; L A Leinwand
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 4.  Nonsense suppression therapies in human genetic diseases.

Authors:  Patrícia Martins-Dias; Luísa Romão
Journal:  Cell Mol Life Sci       Date:  2021-03-22       Impact factor: 9.261

Review 5.  Therapeutics based on stop codon readthrough.

Authors:  Kim M Keeling; Xiaojiao Xue; Gwen Gunn; David M Bedwell
Journal:  Annu Rev Genomics Hum Genet       Date:  2014-04-18       Impact factor: 8.929

6.  Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA.

Authors:  Renata Bordeira-Carriço; Daniel Ferreira; Denisa D Mateus; Hugo Pinheiro; Ana Paula Pêgo; Manuel A S Santos; Carla Oliveira
Journal:  Eur J Hum Genet       Date:  2014-01-15       Impact factor: 4.246

Review 7.  Mutation-Directed Therapeutics for Neurofibromatosis Type I.

Authors:  Andre Leier; David M Bedwell; Ann T Chen; George Dickson; Kim M Keeling; Robert A Kesterson; Bruce R Korf; Tatiana T Marquez Lago; Ulrich F Müller; Linda Popplewell; Jiangbing Zhou; Deeann Wallis
Journal:  Mol Ther Nucleic Acids       Date:  2020-04-29       Impact factor: 8.886

8.  Repurposing tRNAs for nonsense suppression.

Authors:  Suki Albers; Bertrand Beckert; Marco C Matthies; Chandra Sekhar Mandava; Raphael Schuster; Carolin Seuring; Maria Riedner; Suparna Sanyal; Andrew E Torda; Daniel N Wilson; Zoya Ignatova
Journal:  Nat Commun       Date:  2021-06-22       Impact factor: 14.919

9.  Ex vivo correction of selenoprotein N deficiency in rigid spine muscular dystrophy caused by a mutation in the selenocysteine codon.

Authors:  M Rederstorff; V Allamand; P Guicheney; C Gartioux; P Richard; D Chaigne; A Krol; A Lescure
Journal:  Nucleic Acids Res       Date:  2007-11-19       Impact factor: 16.971

Review 10.  Therapeutic promise of engineered nonsense suppressor tRNAs.

Authors:  Joseph J Porter; Christina S Heil; John D Lueck
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-02-10       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.